No mandatory relabelling of drugs after GST cut: Pharma pricing body
The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, has clarified that drug manufacturers need not recall medicines already released in the market before September 22, the implementation date for new GST rates.
NPPA has clarified that medicines and medical devices already in the supply chain before September 22 will not require relabelling.
It has stated that recalling, re-stickering, or re-labelling packs already released into the market is not mandatory.
The move comes after the GST council-led by Finance Minister Nirmala Sitharaman announced to cut GST on drugs and devices to 5 per cent from 18 per cent.
Unlock Exclusive Insights with The Tribune Premium
Take your experience further with Premium access.
Thought-provoking Opinions, Expert Analysis, In-depth Insights and other Member Only Benefits
Already a Member? Sign In Now
